Shiva Medicare has informed that in just concluded meeting of Board of Directors, the Board approved and considered the Unaudited Financial results for the quarter and half year ended September 30, 2018 - Annexure I; Limited Review Report by the Statutory Auditors of the company on Unaudited financial results for the quarter and half year ended September 30, 2018 - Annexure II; Draft Director's Report for the Financial year ending March 31, 2018; the date of 27th Annual General Meeting of the company, to be December 19,2018; and Book Closure Date in connection with AGM between December 13, 2018 to December 19, 2018. This intimation is also being uploaded on the company's website at www.shivamedicate.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: